Compare Illumina, Inc. (ILMN) vs Solstice Advanced Materials Inc. Common Stock (SOLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Solstice Advanced Materials Inc. Common Stock — how do they compare? Illumina, Inc. trades at $272.07 (market cap $41.04B), while Solstice Advanced Materials Inc. Common Stock trades at $59.92 (market cap $9.55B). The key difference: Illumina, Inc. is far larger — about 4.3× Solstice Advanced Materials Inc. Common Stock's market cap, and Solstice Advanced Materials Inc. Common Stock pays a 0.5% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 84 Days and Solstice Advanced Materials Inc. Common Stock for 0 Days on average.
| ILMN | SOLS | |
|---|---|---|
Market Cap | $41.04B | $9.55B |
Volume | 2,120,523 | 2,661,277 |
Sector | Health | Basic Materials |
52-Week High | $293.69 | $88.60 |
52-Week Low | $93.00 | $41.43 |
Typical Hold Time | 84 Days | 0 Days |
Enterprise Value | $42.39B | $11.23B |
Dividend Yield | — | 0.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $271.18, down 1.99% but near its 52-week high of $278.99. The stock shows strong technical momentum with bullish moving averages and has beaten earnings estimates for three consecutive quarters. Revenue remains stable at $4.3B with impressive profitability metrics including 66.4% gross margin and 18.3% net income margin. Recent news highlights S&P 500 inclusion and AI-driven growth initiatives.
ILMN presents a mixed outlook with strong fundamentals and technical momentum offset by premium valuations (P/E 50.6). The primary opportunity lies in genomic sequencing leadership and AI integration, while risks include valuation sensitivity and competitive pressures. Analyst consensus leans bullish with 54% buy ratings but a $241 price target suggests limited upside from current levels.
Solstice Advanced Materials (SOLS) trades at $60.91, up 0.33% with neutral technical signals. The company shows strong profitability with 30.64% gross margins and 14.95% ROE, though Q4 2025 earnings missed expectations. Recent developments include a $49M R&D expansion and termination of the Element Solutions merger, with the board authorizing a $500M share repurchase program. Analyst consensus is bullish with 80% buy ratings and a $80.22 price target representing 32% upside potential.
SOLS presents a compelling growth story with consistent earnings beats and institutional accumulation, though elevated P/E of 46.07 warrants caution. Key risks include execution challenges post-merger termination and margin pressure as profit margins declined from 6.09% to 5.12% year-over-year. The stock offers substantial upside if management delivers on growth initiatives while maintaining current profitability levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Solstice Advanced Materials Inc. Common Stock
Solstice Advanced Materials Inc. is a specialty materials company spun off from Honeywell in 2025, producing low-global-warming-potential refrigerants, blowing agents, and industrial solvents through its Refrigerants and Applied Solutions segment. Its Electronic and Specialty Materials segment supplies semiconductor materials, high-strength fibers, and healthcare-packaging films.
Read more on SOLS →
